Show simple item record

dc.contributor.authorUlger, Y.
dc.contributor.authorOzaras, R.
dc.contributor.authorMert, A.
dc.contributor.authorCanbakan, B.
dc.contributor.authorTabak, F.
dc.contributor.authorSenturk, H.
dc.contributor.authorTahan, V.
dc.contributor.authorUraz, S.
dc.contributor.authorOzbay, G.
dc.date.accessioned2021-03-06T11:22:35Z
dc.date.available2021-03-06T11:22:35Z
dc.date.issued2008
dc.identifier.citationSenturk H., Tahan V., Canbakan B., Uraz S., Ulger Y., Ozaras R., Tabak F., Mert A., Ozbay G., "Chronic hepatitis C responds poorly to combination therapy in chronic hepatitis B carriers", NETHERLANDS JOURNAL OF MEDICINE, cilt.66, ss.191-195, 2008
dc.identifier.issn0300-2977
dc.identifier.othervv_1032021
dc.identifier.otherav_eeb69155-30e5-422b-85cf-9d14efa5dae3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/156703
dc.description.abstractBackground: The effect of conventional interferon-based therapy of hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection is controversial. Yet, no studies have been carried out into pegylated interferon treatment for chronic HBV/HCV coinfection. We aimed to evaluate the response rate and side effects of conventional or pegylated interferon combined with ribavirin on chronic HBV/HCV coinfection therapy.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleChronic hepatitis C responds poorly to combination therapy in chronic hepatitis B carriers
dc.typeMakale
dc.relation.journalNETHERLANDS JOURNAL OF MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume66
dc.identifier.issue5
dc.identifier.startpage191
dc.identifier.endpage195
dc.contributor.firstauthorID41200


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record